Literature DB >> 27795296

PHD2 Is a Regulator for Glycolytic Reprogramming in Macrophages.

Annemarie Guentsch1, Angelika Beneke1, Lija Swain1, Katja Farhat1, Shunmugam Nagarajan1, Ben Wielockx2, Kaamini Raithatha3, Jan Dudek4, Peter Rehling4, Anke Zieseniss1, Aline Jatho1, Mei Chong5, Celio X C Santos5, Ajay M Shah5, Dörthe M Katschinski6.   

Abstract

The prolyl-4-hydroxylase domain (PHD) enzymes are regarded as the molecular oxygen sensors. There is an interplay between oxygen availability and cellular metabolism, which in turn has significant effects on the functionality of innate immune cells, such as macrophages. However, if and how PHD enzymes affect macrophage metabolism are enigmatic. We hypothesized that macrophage metabolism and function can be controlled via manipulation of PHD2. We characterized the metabolic phenotypes of PHD2-deficient RAW cells and primary PHD2 knockout bone marrow-derived macrophages (BMDM). Both showed typical features of anaerobic glycolysis, which were paralleled by increased pyruvate dehydrogenase kinase 1 (PDK1) protein levels and a decreased pyruvate dehydrogenase enzyme activity. Metabolic alterations were associated with an impaired cellular functionality. Inhibition of PDK1 or knockout of hypoxia-inducible factor 1α (HIF-1α) reversed the metabolic phenotype and impaired the functionality of the PHD2-deficient RAW cells and BMDM. Taking these results together, we identified a critical role of PHD2 for a reversible glycolytic reprogramming in macrophages with a direct impact on their function. We suggest that PHD2 serves as an adjustable switch to control macrophage behavior.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  PDK; dioxygenases; hypoxia; macrophages; prolyl-4-hydroxylase domain

Mesh:

Substances:

Year:  2016        PMID: 27795296      PMCID: PMC5192080          DOI: 10.1128/MCB.00236-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

Review 2.  Hypoxia-inducible factors and their roles in energy metabolism.

Authors:  Nobuhito Goda; Mai Kanai
Journal:  Int J Hematol       Date:  2012-04-26       Impact factor: 2.490

3.  Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.

Authors:  Norihiko Takeda; Ellen L O'Dea; Andrew Doedens; Jung-whan Kim; Alexander Weidemann; Christian Stockmann; Masataka Asagiri; M Celeste Simon; Alexander Hoffmann; Randall S Johnson
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

Review 4.  PDK1 inhibitors.

Authors:  Elisa Barile; Surya K De; Maurizio Pellecchia
Journal:  Pharm Pat Anal       Date:  2012-05

5.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.

Authors:  Ioanna Papandreou; Rob A Cairns; Lucrezia Fontana; Ai Lin Lim; Nicholas C Denko
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

6.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

Authors:  Jung-whan Kim; Irina Tchernyshyov; Gregg L Semenza; Chi V Dang
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

7.  Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.

Authors:  Soulafa Mamlouk; Joanna Kalucka; Rashim Pal Singh; Kristin Franke; Antje Muschter; Anika Langer; Christiane Jakob; Max Gassmann; Gustavo B Baretton; Ben Wielockx
Journal:  Int J Cancer       Date:  2013-08-29       Impact factor: 7.396

Review 8.  Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal.

Authors:  Evanna L Mills; Luke A O'Neill
Journal:  Eur J Immunol       Date:  2016-01       Impact factor: 5.532

9.  Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling.

Authors:  Feng Dong; Mazen Khalil; Matt Kiedrowski; Caitlin O'Connor; Erin Petrovic; Xiaorong Zhou; Marc S Penn
Journal:  Circ Res       Date:  2009-12-24       Impact factor: 17.367

10.  Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling.

Authors:  Jiro Ikeda; Toshihiro Ichiki; Hirohide Matsuura; Eriko Inoue; Junji Kishimoto; Aya Watanabe; Chikahiro Sankoda; Shiro Kitamoto; Tomotake Tokunou; Kotaro Takeda; Guo-Hua Fong; Kenji Sunagawa
Journal:  J Am Heart Assoc       Date:  2013-06-18       Impact factor: 5.501

View more
  13 in total

Review 1.  The role of hypoxia-inducible factors in metabolic diseases.

Authors:  Frank J Gonzalez; Cen Xie; Changtao Jiang
Journal:  Nat Rev Endocrinol       Date:  2018-12       Impact factor: 43.330

Review 2.  Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.

Authors:  Sophie Van Welden; Andrew C Selfridge; Pieter Hindryckx
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-30       Impact factor: 46.802

3.  Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses.

Authors:  Moritz J Strowitzki; Gwendolyn Kimmer; Julian Wehrmann; Alina S Ritter; Praveen Radhakrishnan; Vanessa M Opitz; Christopher Tuffs; Marvin Biller; Julia Kugler; Ulrich Keppler; Jonathan M Harnoss; Johannes Klose; Thomas Schmidt; Alfonso Blanco; Cormac T Taylor; Martin Schneider
Journal:  JCI Insight       Date:  2021-03-30

4.  Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses.

Authors:  Pranvera Sadiku; Joseph A Willson; Rebecca S Dickinson; Fiona Murphy; Alison J Harris; Amy Lewis; David Sammut; Ananda S Mirchandani; Eilise Ryan; Emily R Watts; A A Roger Thompson; Helen M Marriott; David H Dockrell; Cormac T Taylor; Martin Schneider; Patrick H Maxwell; Edwin R Chilvers; Massimilliano Mazzone; Veronica Moral; Chris W Pugh; Peter J Ratcliffe; Christopher J Schofield; Bart Ghesquiere; Peter Carmeliet; Moira Kb Whyte; Sarah R Walmsley
Journal:  J Clin Invest       Date:  2017-08-14       Impact factor: 14.808

5.  Loss of PHD3 in myeloid cells dampens the inflammatory response and fibrosis after hind-limb ischemia.

Authors:  Angelika Beneke; Annemarie Guentsch; Annette Hillemann; Anke Zieseniss; Lija Swain; Dörthe M Katschinski
Journal:  Cell Death Dis       Date:  2017-08-10       Impact factor: 8.469

Review 6.  Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses.

Authors:  Alexandre Morrot; Leonardo Marques da Fonseca; Eduardo J Salustiano; Luciana Boffoni Gentile; Luciana Conde; Alessandra Almeida Filardy; Tatiany Nunes Franklim; Kelli Monteiro da Costa; Celio Geraldo Freire-de-Lima; Leonardo Freire-de-Lima
Journal:  Front Oncol       Date:  2018-03-23       Impact factor: 6.244

Review 7.  Hypoxia and the regulation of myeloid cell metabolic imprinting: consequences for the inflammatory response.

Authors:  Pranvera Sadiku; Sarah R Walmsley
Journal:  EMBO Rep       Date:  2019-03-14       Impact factor: 8.807

Review 8.  Metabolic programming of macrophage functions and pathogens control.

Authors:  Sue-Jie Koo; Nisha J Garg
Journal:  Redox Biol       Date:  2019-04-20       Impact factor: 11.799

Review 9.  If it's not one thing, HIF's another: immunoregulation by hypoxia inducible factors in disease.

Authors:  Ffion R Hammond; Amy Lewis; Philip M Elks
Journal:  FEBS J       Date:  2020-07-20       Impact factor: 5.622

Review 10.  The Dynamic Inflammatory Tissue Microenvironment: Signality and Disease Therapy by Biomaterials.

Authors:  Rani Mata; Yuejun Yao; Wangbei Cao; Jie Ding; Tong Zhou; Zihe Zhai; Changyou Gao
Journal:  Research (Wash D C)       Date:  2021-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.